Japan seeks certainty over US and Europe clearing rules – Masamichi Kono interview

So far the European Union and the US have dominated the global debate over the implementation of the central clearing of OTC derivatives. But with key deadlines for both Emir and Dodd-Frank approaching, Masamichi Kono of the Japan Financial Services Agency has serious concerns about the number of outstanding issues

masamichi-kono

Asia Risk: Does the recent move by the Securities and Exchange Commission (SEC) to take a narrower definition of the "US person" rule than the Commodity Futures Trading Commission (CFTC) reassure you that issues posed by US cross-border rules can be resolved?

Masamichi Kono, vice commissioner for international affairs, Japan Financial Services Agency: That's a difficult question to answer because while, of course, we appreciate the fact that the SEC issued such a proposal, it does not solve the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Register

Want to know what’s included in our free membership? Click here

This address will be used to create your account

Switching CCP – How and why?

As uncertainty surrounding Brexit continues and the impacts of Covid-19-driven market volatility are analysed, it is essential for banks and their end-users to understand their clearing options, and how they can achieve greater capital and cross…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here